{"title":"Impact of Empowerment Education Concept Plus Humanistic Care on Moods and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy.","authors":"Baoli Huang, Lijie Lv, Qiwan Zhang","doi":"10.5152/pcp.2025.241011","DOIUrl":null,"url":null,"abstract":"<p><p>Background: To evaluate the clinical efficacy of integrating empowerment education and humanistic care in enhancing cognitive function, self-care ability, mood regulation, and quality of life among lung cancer (LC) patients undergoing chemotherapy. Methods: A total of 149 LC patients receiving chemotherapy from May 2022 to January 2024 were included in the study. They were divided into 2 groups: a control group (n=63) receiving routine care and a joint group (n= 86) receiving empowerment education and humanistic care. Outcomes measured included cognitive function, self-care ability (using the Exercise of Self-Care Agency scale), mood (using the Hospital Anxiety and Depression Scale), cancer-related fatigue (using the Revised Piper Fatigue Scale), adverse reactions, and QoL (using the Functional Assessment of Cancer Therapy-Lung scale). Results: The joint group exhibited significant improvements in cognitive function, self-care ability, and QoL compared to the control group (P < .05). They also had lower scores in anxiety, depression, and cancer-related fatigue (P < .05). The incidence of adverse reactions was markedly lower in the joint group (10.47%) compared to the control group (39.68%). Conclusion: Combining empowerment education with humanistic care effectively improves cognitive function, reduces negative emotions and adverse reactions, enhances self-care ability, and improves the overall QoL of LC patients undergoing chemotherapy.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"35 3","pages":"275-284"},"PeriodicalIF":0.6000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry and Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/pcp.2025.241011","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To evaluate the clinical efficacy of integrating empowerment education and humanistic care in enhancing cognitive function, self-care ability, mood regulation, and quality of life among lung cancer (LC) patients undergoing chemotherapy. Methods: A total of 149 LC patients receiving chemotherapy from May 2022 to January 2024 were included in the study. They were divided into 2 groups: a control group (n=63) receiving routine care and a joint group (n= 86) receiving empowerment education and humanistic care. Outcomes measured included cognitive function, self-care ability (using the Exercise of Self-Care Agency scale), mood (using the Hospital Anxiety and Depression Scale), cancer-related fatigue (using the Revised Piper Fatigue Scale), adverse reactions, and QoL (using the Functional Assessment of Cancer Therapy-Lung scale). Results: The joint group exhibited significant improvements in cognitive function, self-care ability, and QoL compared to the control group (P < .05). They also had lower scores in anxiety, depression, and cancer-related fatigue (P < .05). The incidence of adverse reactions was markedly lower in the joint group (10.47%) compared to the control group (39.68%). Conclusion: Combining empowerment education with humanistic care effectively improves cognitive function, reduces negative emotions and adverse reactions, enhances self-care ability, and improves the overall QoL of LC patients undergoing chemotherapy.
期刊介绍:
Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.